{
  "main_header": {
    "sid": 469912,
    "name": "Lactose (India)",
    "stock_name": "Lactose (India)",
    "full_name": "Lactose (India) Ltd",
    "name_url": "stocks-analysis/lactose-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "118.00",
    "chg": 0.4,
    "chgp": "0.34%",
    "dir": 1,
    "prev_price": "117.60",
    "mcapval": "154.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524202,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE058I01013",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "940 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lactose-india-469912-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Lactose (India) falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lactose-india-fallingrising-3747170",
        "imagepath": "",
        "date": "2025-12-05 00:44:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Volatility</strong></p>\n<p>After enduring a challenging run, with the stock falling nearly 50% over the past year and underperforming the Sensex by a wide margin, Lactose (India) demonstrated a sharp intraday recovery on 04-Dec. The stock touched an intraday high of ₹119, representing an 8.73% gain from its previous close, before settling slightly lower but still maintaining a strong 7.81% increase. This rebound is particularly significant given the stock’s recent volatility, with an intraday price range of ₹12 and a calculated volatility of 5.31% based on the weighted average price. Such fluctuations indicate heightened trading activity and investor interest.</p>\n<p><strong>Investor Participation and Trading Dynamics</strong></p>\n<p>One of the key drivers behind th..."
      },
      {
        "title": "Why is Lactose (India) falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lactose-india-fallingrising-3708120",
        "imagepath": "",
        "date": "2025-11-17 21:26:38",
        "description": "As of 17-Nov, Lactose (India) Ltd is experiencing a price increase, currently at Rs 126.40, reflecting a rise of Rs 11.4 or 9.91%. The stock has shown strong performance today, outperforming its sector by 9.63% and has gained consecutively over the last three days, accumulating a total return of 18.02% during this period. It opened with a significant gain of 3.43% and reached an intraday high of Rs 126.5, which is a 10% increase. Additionally, Lactose (India) is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The recent increase in investor participation, with a 63.43% rise in delivery volume compared to the 5-day average, further supports the stock's upward movement. There is no information available regarding positive or negative factors that could influence the stock.\n\nBroader market context shows that Lactose (India) has significantly outperfor..."
      },
      {
        "title": "Lactose (India) Ltd Gains 10% Today, Surpassing Sensex Amid Strong Buying Activity and Milestones",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-gains-10-today-surpassing-sensex-amid-strong-buying-activity-and-milestones-3707705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LactoseIndia_only_buyers_3707705.png",
        "date": "2025-11-17 14:00:20",
        "description": "Lactose (India) Ltd is experiencing notable buying activity, with a significant stock increase today and a strong performance over the past week. The stock has shown resilience despite earlier challenges, reflecting a positive trend in the pharmaceuticals and biotechnology sector, supported by robust buyer sentiment."
      },
      {
        "title": "Why is Lactose (India) falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lactose-india-fallingrising-3702294",
        "imagepath": "",
        "date": "2025-11-14 21:38:25",
        "description": "As of 14-Nov, Lactose (India) Ltd is experiencing a price increase, currently at 115.00, which reflects a rise of 7.1 or 6.58%. The stock has shown positive momentum, gaining 7.28% over the last two days, despite opening with a loss of 2.55% today. It reached an intraday high of Rs 118, indicating strong upward movement during the trading session. However, the stock has been volatile, with an intraday volatility of 7.24%, and it has traded in a wide range of Rs 15.95. In terms of performance against benchmarks, the stock has outperformed its sector by 6.12%, but its year-to-date return remains significantly negative at -46.73%. Additionally, there has been a decline in investor participation, with delivery volume falling by 36.13% against the 5-day average, which may impact future price movements.\n\nBroader Market Context: In the short term, Lactose (India) Ltd has outperformed the Sensex, which has only inc..."
      },
      {
        "title": "Lactose (India) Reports Strong Financial Metrics Amidst Cash Flow Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-financial-trend-improves-from-negative-to-positive-amid-record-sales-and-profit-ratios-3701206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LactoseIndia_fintrenddot_3701206.png",
        "date": "2025-11-14 11:01:19",
        "description": "Lactose (India) reported strong financial metrics for the quarter ending September 2025, with record net sales of Rs 41.18 crore and a robust operating profit to interest ratio. However, challenges persist, including negative operating cash flow and a significant decline in profit after tax over the nine-month period."
      },
      {
        "title": "Lactose (India) Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/lactose-india-q2-fy26-strong-revenue-growth-masks-margin-erosion-concerns-3712567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LactoseIndia_quaterlyResult_3712567.png",
        "date": "2025-11-14 09:26:23",
        "description": "Lactose (India) Ltd., a Gujarat-based pharmaceutical and dairy products manufacturer, reported net profit of ₹2.16 crores for Q2 FY26, marking a 44.00% sequential increase from ₹1.50 crores in Q1 FY26 and a 6.40% rise from ₹2.03 crores in Q2 FY25. Despite the profit growth, the company's shares have struggled significantly, plunging 36.14% over the past year and trading at ₹107.70 as of November 14, 2025, reflecting investor concerns about operational efficiency and margin sustainability."
      },
      {
        "title": "How has been the historical performance of Lactose (India)?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lactose-india-3698816",
        "imagepath": "",
        "date": "2025-11-13 23:12:54",
        "description": "Answer:\nThe historical performance of Lactose (India) shows a significant growth trajectory in net sales and profitability over the years, with net sales increasing from INR 34.96 crore in March 2021 to INR 116.40 crore in March 2025. The total operating income has mirrored this growth, reaching INR 116.40 crore in March 2025, up from INR 34.96 crore in March 2021. The operating profit (PBDIT) has also seen fluctuations, peaking at INR 20.13 crore in March 2024 before slightly declining to INR 18.41 crore in March 2025. Profit before tax has improved from a loss of INR 3.27 crore in March 2021 to a profit of INR 6.92 crore in March 2025, while profit after tax followed a similar trend, rising from a loss of INR 2.48 crore in March 2021 to INR 5.16 crore in March 2025. \n\nIn terms of expenses, raw material costs have increased significantly, reaching INR 60.51 crore in March 2025, which reflects the rising op..."
      },
      {
        "title": "Lactose (India) Faces Evaluation Shift Amidst Declining Performance and High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-stock-downgraded-to-strong-sell-amid-bearish-trends-3696479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LactoseIndia_mojoScore_3696479.png",
        "date": "2025-11-13 08:03:09",
        "description": "Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting ongoing challenges. The company's performance indicators present a mixed outlook, with concerns over its high Debt to EBITDA ratio and significant profit decline, contributing to its underperformance against broader market indices."
      },
      {
        "title": "How has been the historical performance of Lactose (India)?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lactose-india-3695034",
        "imagepath": "",
        "date": "2025-11-13 00:04:48",
        "description": "Answer:\nThe historical performance of Lactose (India) shows a significant growth trend in net sales and profitability over the years, with net sales increasing from 34.96 Cr in Mar'21 to 116.40 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 40.61 Cr in Mar'19 to 116.40 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated growth, reaching 18.41 Cr in Mar'25, although it peaked at 20.13 Cr in Mar'24. Profit before tax saw fluctuations, with a notable increase to 6.92 Cr in Mar'25 from a loss of 3.27 Cr in Mar'21. Profit after tax also improved, reaching 5.16 Cr in Mar'25, compared to a loss of 2.48 Cr in Mar'21. The earnings per share (EPS) rose to 4.1 in Mar'25 from a negative EPS in Mar'21. On the balance sheet, total assets increased from 84.00 Cr in Mar'20 to 133.47 Cr in Mar'25, while total liabilities also grew, reflecting a rise from 36.03 Cr in Ma..."
      }
    ],
    "total": 166,
    "sid": "469912",
    "stock_news_url": "https://www.marketsmojo.com/news/lactose-india-469912"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to Regulation 30 & 47(3) of SEBI (LODR) Regulations 2015 we hereby submit the newspaper publication of financial results for the quarter ended 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th November 2025",
      "datetime": "13-Nov-2025",
      "details": "In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Board of Directors at their meeting held today viz. 13th November 2025 has inter-alia approved the following items; 1. Un-Audited Financial Results of the Company along with the Limited Review Report issued by Statutory Auditor of the company for the second quarter ended 30th September 2025; 2. Any other business as decided with the permission of the chairman.",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For The Quarter Ended 30Th September 2025",
      "datetime": "13-Nov-2025",
      "details": "Pursuant to Regulation 33 of the SEBI (LODR) Regulations 2015 we hereby submit the Standalone Financial Results for the quarter ended 30th September 2025 along with the Limited Review Report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Lactose (India) falling/rising?

2025-12-05 00:44:18

Recent Price Movement and Volatility

After enduring a challenging run, with the stock falling nearly 50% over the past year and underperforming the Sensex by a wide margin, Lactose (India) demonstrated a sharp intraday recovery on 04-Dec. The stock touched an intraday high of ₹119, representing an 8.73% gain from its previous close, before settling slightly lower but still maintaining a strong 7.81% increase. This rebound is particularly significant given the stock’s recent volatility, with an intraday price range of ₹12 and a calculated volatility of 5.31% based on the weighted average price. Such fluctuations indicate heightened trading activity and investor interest.

Investor Participation and Trading Dynamics

One of the key drivers behind th...

Read More

Why is Lactose (India) falling/rising?

2025-11-17 21:26:38

As of 17-Nov, Lactose (India) Ltd is experiencing a price increase, currently at Rs 126.40, reflecting a rise of Rs 11.4 or 9.91%. The stock has shown strong performance today, outperforming its sector by 9.63% and has gained consecutively over the last three days, accumulating a total return of 18.02% during this period. It opened with a significant gain of 3.43% and reached an intraday high of Rs 126.5, which is a 10% increase. Additionally, Lactose (India) is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The recent increase in investor participation, with a 63.43% rise in delivery volume compared to the 5-day average, further supports the stock's upward movement. There is no information available regarding positive or negative factors that could influence the stock. Broader market context shows that Lactose (India) has significantly outperfor...

Read More

Lactose (India) Ltd Gains 10% Today, Surpassing Sensex Amid Strong Buying Activity and Milestones

2025-11-17 14:00:20

Lactose (India) Ltd is experiencing notable buying activity, with a significant stock increase today and a strong performance over the past week. The stock has shown resilience despite earlier challenges, reflecting a positive trend in the pharmaceuticals and biotechnology sector, supported by robust buyer sentiment.

Read More

Why is Lactose (India) falling/rising?

2025-11-14 21:38:25

As of 14-Nov, Lactose (India) Ltd is experiencing a price increase, currently at 115.00, which reflects a rise of 7.1 or 6.58%. The stock has shown positive momentum, gaining 7.28% over the last two days, despite opening with a loss of 2.55% today. It reached an intraday high of Rs 118, indicating strong upward movement during the trading session. However, the stock has been volatile, with an intraday volatility of 7.24%, and it has traded in a wide range of Rs 15.95. In terms of performance against benchmarks, the stock has outperformed its sector by 6.12%, but its year-to-date return remains significantly negative at -46.73%. Additionally, there has been a decline in investor participation, with delivery volume falling by 36.13% against the 5-day average, which may impact future price movements. Broader Market Context: In the short term, Lactose (India) Ltd has outperformed the Sensex, which has only inc...

Read More

Lactose (India) Reports Strong Financial Metrics Amidst Cash Flow Challenges

2025-11-14 11:01:19

Lactose (India) reported strong financial metrics for the quarter ending September 2025, with record net sales of Rs 41.18 crore and a robust operating profit to interest ratio. However, challenges persist, including negative operating cash flow and a significant decline in profit after tax over the nine-month period.

Read More

Lactose (India) Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns

2025-11-14 09:26:23

Lactose (India) Ltd., a Gujarat-based pharmaceutical and dairy products manufacturer, reported net profit of ₹2.16 crores for Q2 FY26, marking a 44.00% sequential increase from ₹1.50 crores in Q1 FY26 and a 6.40% rise from ₹2.03 crores in Q2 FY25. Despite the profit growth, the company's shares have struggled significantly, plunging 36.14% over the past year and trading at ₹107.70 as of November 14, 2025, reflecting investor concerns about operational efficiency and margin sustainability.

Read More

How has been the historical performance of Lactose (India)?

2025-11-13 23:12:54

Answer: The historical performance of Lactose (India) shows a significant growth trajectory in net sales and profitability over the years, with net sales increasing from INR 34.96 crore in March 2021 to INR 116.40 crore in March 2025. The total operating income has mirrored this growth, reaching INR 116.40 crore in March 2025, up from INR 34.96 crore in March 2021. The operating profit (PBDIT) has also seen fluctuations, peaking at INR 20.13 crore in March 2024 before slightly declining to INR 18.41 crore in March 2025. Profit before tax has improved from a loss of INR 3.27 crore in March 2021 to a profit of INR 6.92 crore in March 2025, while profit after tax followed a similar trend, rising from a loss of INR 2.48 crore in March 2021 to INR 5.16 crore in March 2025. In terms of expenses, raw material costs have increased significantly, reaching INR 60.51 crore in March 2025, which reflects the rising op...

Read More

Lactose (India) Faces Evaluation Shift Amidst Declining Performance and High Debt Concerns

2025-11-13 08:03:09

Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting ongoing challenges. The company's performance indicators present a mixed outlook, with concerns over its high Debt to EBITDA ratio and significant profit decline, contributing to its underperformance against broader market indices.

Read More

How has been the historical performance of Lactose (India)?

2025-11-13 00:04:48

Answer: The historical performance of Lactose (India) shows a significant growth trend in net sales and profitability over the years, with net sales increasing from 34.96 Cr in Mar'21 to 116.40 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 40.61 Cr in Mar'19 to 116.40 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated growth, reaching 18.41 Cr in Mar'25, although it peaked at 20.13 Cr in Mar'24. Profit before tax saw fluctuations, with a notable increase to 6.92 Cr in Mar'25 from a loss of 3.27 Cr in Mar'21. Profit after tax also improved, reaching 5.16 Cr in Mar'25, compared to a loss of 2.48 Cr in Mar'21. The earnings per share (EPS) rose to 4.1 in Mar'25 from a negative EPS in Mar'21. On the balance sheet, total assets increased from 84.00 Cr in Mar'20 to 133.47 Cr in Mar'25, while total liabilities also grew, reflecting a rise from 36.03 Cr in Ma...

Read More

View All News